nodes	percent_of_prediction	percent_of_DWPC	metapath
Procyclidine—CHRM1—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0317	0.0322	CbGpPWpGaD
Procyclidine—CHRM4—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0313	0.0319	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Other—GNRHR—adrenal gland cancer	0.0312	0.0318	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0309	0.0315	CbGpPWpGaD
Procyclidine—CHRM1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0211	0.0215	CbGpPWpGaD
Procyclidine—CHRM3—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0211	0.0214	CbGpPWpGaD
Procyclidine—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0209	0.0212	CbGpPWpGaD
Procyclidine—Biperiden—ABCB1—adrenal gland cancer	0.018	1	CrCbGaD
Procyclidine—CHRM1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0176	0.0179	CbGpPWpGaD
Procyclidine—CHRM3—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0176	0.0179	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0173	0.0176	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0158	0.016	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0157	0.016	CbGpPWpGaD
Procyclidine—CHRM3—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.0137	0.0139	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0132	0.0134	CbGpPWpGaD
Procyclidine—CHRM4—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.012	0.0122	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0117	0.0119	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0116	0.0118	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0115	0.0117	CbGpPWpGaD
Procyclidine—CHRM3—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.0111	0.0113	CbGpPWpGaD
Procyclidine—CHRM3—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.0108	0.011	CbGpPWpGaD
Procyclidine—CHRM1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0106	0.0107	CbGpPWpGaD
Procyclidine—CHRM3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0105	0.0107	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0104	0.0106	CbGpPWpGaD
Procyclidine—CHRM4—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.0102	0.0104	CbGpPWpGaD
Procyclidine—CHRM4—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00973	0.00991	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00944	0.00961	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00941	0.00958	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00924	0.00941	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00888	0.00905	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00886	0.00902	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00877	0.00893	CbGpPWpGaD
Procyclidine—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00872	0.00888	CbGpPWpGaD
Procyclidine—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.0081	0.00824	CbGpPWpGaD
Procyclidine—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00807	0.00822	CbGpPWpGaD
Procyclidine—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00799	0.00814	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00789	0.00804	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0077	0.00785	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00745	0.00758	CbGpPWpGaD
Procyclidine—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00724	0.00737	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—TSHR—adrenal gland cancer	0.00704	0.00716	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00699	0.00712	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00697	0.00709	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0069	0.00703	CbGpPWpGaD
Procyclidine—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00687	0.00699	CbGpPWpGaD
Procyclidine—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00685	0.00697	CbGpPWpGaD
Procyclidine—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00678	0.0069	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00676	0.00689	CbGpPWpGaD
Procyclidine—CHRM4—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00676	0.00688	CbGpPWpGaD
Procyclidine—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00656	0.00668	CbGpPWpGaD
Procyclidine—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00654	0.00666	CbGpPWpGaD
Procyclidine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00648	0.0066	CbGpPWpGaD
Procyclidine—CHRM4—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00647	0.00659	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00623	0.00634	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00621	0.00632	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00615	0.00626	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00532	0.00542	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00531	0.0054	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00525	0.00535	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00502	0.00511	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.005	0.0051	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00496	0.00505	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00474	0.00483	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00473	0.00482	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00468	0.00477	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00456	0.00464	CbGpPWpGaD
Procyclidine—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00455	0.00463	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00454	0.00463	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0045	0.00458	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0045	0.00458	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00446	0.00454	CbGpPWpGaD
Procyclidine—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00436	0.00444	CbGpPWpGaD
Procyclidine—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00435	0.00443	CbGpPWpGaD
Procyclidine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00431	0.00439	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00409	0.00417	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00405	0.00413	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.00399	0.00407	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00398	0.00405	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00371	0.00378	CbGpPWpGaD
Procyclidine—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.0037	0.00377	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00362	0.00368	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00361	0.00368	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00351	0.00357	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00349	0.00356	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00303	0.00308	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00301	0.00306	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.003	0.00306	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.003	0.00305	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00297	0.00302	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00276	0.00281	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	0.00276	0.00281	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00275	0.0028	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00273	0.00278	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00272	0.00277	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00272	0.00277	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0027	0.00275	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00269	0.00274	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00268	0.00273	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00268	0.00273	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00267	0.00272	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00266	0.00271	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00265	0.00269	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00259	0.00264	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0025	0.00255	CbGpPWpGaD
Procyclidine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.0025	0.00254	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0025	0.00254	CbGpPWpGaD
Procyclidine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00249	0.00254	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00247	0.00252	CbGpPWpGaD
Procyclidine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00247	0.00251	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00244	0.00248	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00243	0.00248	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00243	0.00248	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00243	0.00247	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00242	0.00246	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00241	0.00245	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.0024	0.00245	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00239	0.00244	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00235	0.0024	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00235	0.00239	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00232	0.00237	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00231	0.00236	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00226	0.0023	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00226	0.0023	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	0.0022	0.00224	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00219	0.00223	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	0.00213	0.00217	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	0.0021	0.00214	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	0.00201	0.00204	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00186	0.0019	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00186	0.00189	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00186	0.00189	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00185	0.00189	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00183	0.00187	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00175	0.00178	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00174	0.00177	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00172	0.00176	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00169	0.00172	CbGpPWpGaD
Procyclidine—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00165	0.00168	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00163	0.00166	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00163	0.00166	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00161	0.00164	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00161	0.00164	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00161	0.00164	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00159	0.00162	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00156	0.00159	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	0.00156	0.00159	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00155	0.00158	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00154	0.00157	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	0.00153	0.00156	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00148	0.00151	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00148	0.0015	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00148	0.0015	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00147	0.0015	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00146	0.00149	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00146	0.00148	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00144	0.00146	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.00143	0.00146	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.00142	0.00145	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00142	0.00144	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	0.00141	0.00144	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00141	0.00144	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.0014	0.00142	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.00135	0.00138	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.00135	0.00137	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.00133	0.00136	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	0.0013	0.00132	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	0.00125	0.00127	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	0.00124	0.00126	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.00123	0.00125	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	0.00121	0.00123	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00105	0.00107	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.00105	0.00107	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	0.00104	0.00106	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.00104	0.00106	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00103	0.00105	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.00103	0.00105	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.00102	0.00104	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000997	0.00102	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000979	0.000997	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000953	0.000971	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.00095	0.000968	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000941	0.000958	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.000906	0.000923	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000875	0.000892	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000873	0.000889	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000864	0.00088	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000844	0.000859	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000841	0.000857	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000837	0.000852	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.000835	0.000851	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000834	0.000849	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000833	0.000848	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000826	0.000841	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	0.000825	0.00084	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000816	0.000831	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000813	0.000828	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000805	0.00082	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	0.0008	0.000814	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000702	0.000715	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.0007	0.000713	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000693	0.000706	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000671	0.000684	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000611	0.000622	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000609	0.00062	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000603	0.000614	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000596	0.000607	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000563	0.000574	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000561	0.000572	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000556	0.000566	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000556	0.000566	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000554	0.000565	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000549	0.000559	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000539	0.000549	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000537	0.000547	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000536	0.000545	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000532	0.000542	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	0.000472	0.000481	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000402	0.000409	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000401	0.000408	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000397	0.000404	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	0.000397	0.000404	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000318	0.000324	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000317	0.000323	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000314	0.00032	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000267	0.000272	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000267	0.000271	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000264	0.000269	CbGpPWpGaD
